NUMA1 and urinary bladder cancer: Nuclear matrix protein 22 (NMP22 or NuMA) and human complement factor H related protein (hCFHrp) are two Food and Drug Administration (FDA) approved biomarkers for bladder cancer detection with reported high sensitivity.9, 10